Virpax Pharmaceuticals, Inc.
VRPX
$0.30
$0.04417.19%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.51M | 17.20K | 1.87M | 1.87M | 9.14M |
| Total Receivables | -- | 116.80K | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 39.50K | 44.50K | 591.80K | 758.40K | 203.50K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 3.10K | 125.60K | 128.10K | 505.90K | 283.40K |
| Total Current Assets | 1.56M | 304.20K | 2.59M | 3.13M | 9.63M |
|
|
|||||
| Total Current Assets | 1.56M | 304.20K | 2.59M | 3.13M | 9.63M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 1.56M | 304.20K | 2.59M | 3.13M | 9.63M |
|
|
|||||
| Total Accounts Payable | 41.10K | 96.30K | 75.40K | 13.30K | 18.50K |
| Total Accrued Expenses | 2.43M | 2.26M | 2.81M | 1.83M | 1.68M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | 2.50M | 2.50M | 6.00M |
| Total Other Current Liabilities | -- | -- | 2.50M | 2.50M | 6.00M |
| Total Current Liabilities | 2.47M | 2.36M | 5.39M | 4.34M | 7.69M |
|
|
|||||
| Total Current Liabilities | 2.47M | 2.36M | 5.39M | 4.34M | 7.69M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.47M | 2.36M | 5.39M | 4.34M | 7.69M |
|
|
|||||
| Common Stock & APIC | 70.70M | 66.17M | 63.42M | 61.55M | 61.48M |
| Retained Earnings | -71.61M | -68.22M | -66.21M | -62.76M | -59.54M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -913.80K | -2.05M | -2.79M | -1.21M | 1.93M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -913.80K | -2.05M | -2.79M | -1.21M | 1.93M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -913.80K | -2.05M | -2.79M | -1.21M | 1.93M |
|
|
|||||